| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.0008 |